Food crops shouldn’t produce experimental drugs
This letter was sent to the following Washington state legislators on the Senate Rules Committee, and Senate Ways and Means Committee:
|
Sen. Dale Brandland Sen. Lisa Brown Sen. Mark Doumit Sen. Tracey Eide Sen. Luke Esser Sen. Darlene Fairley Sen. Bill Finkbeiner Sen. Rosa Franklin Sen. Karen Fraser Sen. Mary Margaret Haugen |
Sen. Mike Hewitt Sen. Jim Honeyford Sen. Ken Jacobsen Sen. Stephen Johnson Sen. Adam Kline Sen. Jeanne Kohl-Welles Sen. Linda Evans Parlette Sen. Margarita Prentice Sen. Craig Pridemore |
Sen. Marilyn Rasmussen Sen. Debbie Regala Sen. Pam Roach Sen. Phil Rockefeller Sen. Mark Schoesler Sen. Harriet Spanel Sen. Val Stevens Sen. Pat Thibaudeau Sen. Joseph Zarelli |
March 2, 2006
Dear Senator :
I’m writing to urge you to sponsor and support a floor amendment to SHB 2640, “Providing biotechnology product and medical device manufacturing tax incentives” (see http://apps.leg.wa.gov/billinfo/Summary.aspx?bill=6462&year=2005).
Experimental “biopharming” should not be eligible for the tax incentives outlined by SHB 2640. We’re aware you may not know about this secretive and highly experimental technology. It involves engineering common food crops to become virtual factories for experimental pharmaceutical and industrial chemicals.
The National Academies of Science has warned in two reports, that these untested, unproven biopharm compounds cannot be contained or kept from contaminating the food supply if food crops are used to produce them. Secretive, open-air biopharming experiments already have been planted in Washington farm fields by Washington State University and a Canadian company, SemBioSys. See last Friday’s (February 24) editorial in the Seattle Post Intelligencer, “Are there human genes in your food?” online at http://seattlepi.nwsource.com/opinion/260676_farm24.html.
As a consumer-owned business doing $100 million a year in sales, with 37,000 members, and farmers across the state, we are deeply opposed to any such tax incentives because of the risks of biopharming. We urge you to sponsor a floor amendment to SHB 2640 and hope that in the future you’ll consider supporting legislation to better regulate this dangerous practice.
Suggested amendment:
“Whereas consumers do not want experimental drugs and industrial
chemicals in their food without their knowledge or consent, andWhereas the National Academy of Sciences warns that it’s virtually impossible to keep biopharmaceuticals and biochemicals out of the food supply if food crops are used to grow them experimentally, and
Whereas agriculture and the food industry are the largest employers and the greatest source of revenue in Washington state and biopharms pose a great financial risk,
Therefore, tax incentives shall not be extended to companies or
institutions that engineer food crops to produce synthetic drugs or chemicals.”
Thank you for your support,
Tracy Wolpert
Chief Executive Officer
PCC Natural Markets